Skip to content

Richard Clinton Becker

Duke Clinical Research Institute

2 papers in the Anchorcite directory, published between 2009 and 2011, cited 16,702 times in total.

ORCID profile

Research topics

Frequent co-authors

  • Kenneth W. Mahaffey · 2 papers
  • Manesh R. Patel · 1 paper
  • Jyotsna Garg · 1 paper
  • Guohua Pan · 1 paper
  • Daniel E. Singer · 1 paper
  • Werner Hacke · 1 paper
  • GÜNTER E. BREITHARDT · 1 paper
  • Jonathan L. Halperin · 1 paper

Papers

  1. Rivaroxaban versus Warfarin in Nonvalvular Atrial FibrillationNew England Journal of Medicine · 2011 · 9,529 citations

    BACKGROUND: The use of warfarin reduces the rate of ischemic stroke in patients with atrial fibrillation but requires frequent monitoring and dose adjustment. Rivaroxaban, an oral factor Xa inhibitor, may provide more consistent and predictable anticoagulation than warfarin. METHODS: In…

  2. Ticagrelor versus Clopidogrel in Patients with Acute Coronary SyndromesNew England Journal of Medicine · 2009 · 7,173 citations

    BACKGROUND: Ticagrelor is an oral, reversible, direct-acting inhibitor of the adenosine diphosphate receptor P2Y12 that has a more rapid onset and more pronounced platelet inhibition than clopidogrel. METHODS: In this multicenter, double-blind, randomized trial, we compared ticagrelor (180-mg loading dose,…

Metadata from OpenAlex (CC0).